325 related articles for article (PubMed ID: 29883716)
1. Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances mitochondrial biogenesis during myogenesis.
Theeuwes WF; Gosker HR; Langen RCJ; Pansters NAM; Schols AMWJ; Remels AHV
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2913-2926. PubMed ID: 29883716
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism.
Theeuwes WF; Gosker HR; Langen RCJ; Verhees KJP; Pansters NAM; Schols AMWJ; Remels AHV
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3075-3086. PubMed ID: 28943449
[TBL] [Abstract][Full Text] [Related]
3. Recovery of muscle mass and muscle oxidative phenotype following disuse does not require GSK-3 inactivation.
Theeuwes WF; Pansters NAM; Gosker HR; Schols AMWJ; Verhees KJP; de Theije CC; van Gorp RHP; Kelders MCJM; Ronda O; Haegens A; Remels AHV; Langen RCJ
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165740. PubMed ID: 32087280
[TBL] [Abstract][Full Text] [Related]
4. Regulation of PGC-1α expression by a GSK-3β-TFEB signaling axis in skeletal muscle.
Theeuwes WF; Gosker HR; Schols AMWJ; Langen RCJ; Remels AHV
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118610. PubMed ID: 31738957
[TBL] [Abstract][Full Text] [Related]
5. Muscle-specific GSK-3β ablation accelerates regeneration of disuse-atrophied skeletal muscle.
Pansters NA; Schols AM; Verhees KJ; de Theije CC; Snepvangers FJ; Kelders MC; Ubags ND; Haegens A; Langen RC
Biochim Biophys Acta; 2015 Mar; 1852(3):490-506. PubMed ID: 25496993
[TBL] [Abstract][Full Text] [Related]
6. Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta.
van der Velden JL; Langen RC; Kelders MC; Willems J; Wouters EF; Janssen-Heininger YM; Schols AM
Am J Physiol Cell Physiol; 2007 May; 292(5):C1636-44. PubMed ID: 17166938
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glycogen synthase kinase-3β attenuates glucocorticoid-induced suppression of myogenic differentiation in vitro.
Ma Z; Zhong Z; Zheng Z; Shi XM; Zhang W
PLoS One; 2014; 9(8):e105528. PubMed ID: 25127359
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.
van der Velden JL; Langen RC; Kelders MC; Wouters EF; Janssen-Heininger YM; Schols AM
Am J Physiol Cell Physiol; 2006 Feb; 290(2):C453-62. PubMed ID: 16162663
[TBL] [Abstract][Full Text] [Related]
9. Mitophagy is required for mitochondrial biogenesis and myogenic differentiation of C2C12 myoblasts.
Sin J; Andres AM; Taylor DJ; Weston T; Hiraumi Y; Stotland A; Kim BJ; Huang C; Doran KS; Gottlieb RA
Autophagy; 2016; 12(2):369-80. PubMed ID: 26566717
[TBL] [Abstract][Full Text] [Related]
10. Curcumin ameliorates CKD-induced mitochondrial dysfunction and oxidative stress through inhibiting GSK-3β activity.
Wang D; Yang Y; Zou X; Zheng Z; Zhang J
J Nutr Biochem; 2020 Sep; 83():108404. PubMed ID: 32531667
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3.
van der Velden JLJ; Schols AMWJ; Willems J; Kelders MCJM; Langen RCJ
J Biol Chem; 2008 Jan; 283(1):358-366. PubMed ID: 17977834
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mitochondrial biogenesis during myogenesis.
Remels AH; Langen RC; Schrauwen P; Schaart G; Schols AM; Gosker HR
Mol Cell Endocrinol; 2010 Feb; 315(1-2):113-20. PubMed ID: 19804813
[TBL] [Abstract][Full Text] [Related]
14. FTO is required for myogenesis by positively regulating mTOR-PGC-1α pathway-mediated mitochondria biogenesis.
Wang X; Huang N; Yang M; Wei D; Tai H; Han X; Gong H; Zhou J; Qin J; Wei X; Chen H; Fang T; Xiao H
Cell Death Dis; 2017 Mar; 8(3):e2702. PubMed ID: 28333151
[TBL] [Abstract][Full Text] [Related]
15. Role of the α2 subunit of AMP-activated protein kinase and its nuclear localization in mitochondria and energy metabolism-related gene expressions in C2C12 cells.
Okamoto S; Asgar NF; Yokota S; Saito K; Minokoshi Y
Metabolism; 2019 Jan; 90():52-68. PubMed ID: 30359677
[TBL] [Abstract][Full Text] [Related]
16. Leptin impairs myogenesis in C2C12 cells through JAK/STAT and MEK signaling pathways.
Pijet M; Pijet B; Litwiniuk A; Pajak B; Gajkowska B; Orzechowski A
Cytokine; 2013 Feb; 61(2):445-54. PubMed ID: 23201486
[TBL] [Abstract][Full Text] [Related]
17. Suppression of GSK-3β activation by M-cadherin protects myoblasts against mitochondria-associated apoptosis during myogenic differentiation.
Wang Y; Hao Y; Alway SE
J Cell Sci; 2011 Nov; 124(Pt 22):3835-47. PubMed ID: 22114306
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle.
Dionyssiou MG; Nowacki NB; Hashemi S; Zhao J; Kerr A; Tsushima RG; McDermott JC
J Mol Cell Cardiol; 2013 Jan; 54():35-44. PubMed ID: 23137781
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway.
Murray J; Huss JM
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C630-45. PubMed ID: 21562305
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcase deficiency suppresses skeletal myogenesis and insulin sensitivity in mice through the modulation of mitochondrial homeostasis.
Wang X; Feng Z; Wang X; Yang L; Han S; Cao K; Xu J; Zhao L; Zhang Y; Liu J
Diabetologia; 2016 Jun; 59(6):1287-96. PubMed ID: 26993634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
